{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:33:46Z","timestamp":1762781626458},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T00:00:00Z","timestamp":1291075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1208\/s12249-010-9546-1","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T21:32:50Z","timestamp":1291066370000},"page":"1703-1712","source":"Crossref","is-referenced-by-count":18,"title":["A Comprehensive Development Strategy in Buccal Drug Delivery"],"prefix":"10.1208","volume":"11","author":[{"given":"Ana","family":"Figueiras","sequence":"first","affiliation":[]},{"given":"Alberto A. C. C.","family":"Pais","sequence":"additional","affiliation":[]},{"given":"Francisco J. B.","family":"Veiga","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,11,30]]},"reference":[{"key":"9546_CR1","first-page":"271","volume":"8","author":"ME Vries De","year":"1991","unstructured":"De Vries ME, Bodde HE, Verhoef JC, Junginger HE. Developments in buccal drug delivery. Crit Dev Ther Drug Carrier Syst. 1991;8:271\u2013303.","journal-title":"Crit Dev Ther Drug Carrier Syst"},{"key":"9546_CR2","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1002\/jps.20409","volume":"94","author":"ID Consuelo Del","year":"2005","unstructured":"Del Consuelo ID, Pizzolato G, Falson F, Guy RH, Jacques Y. Evaluations of pig esophageal mucosa as a permeability barrier model for buccal tissue. J Pharm Sci. 2005;94:2777\u201388.","journal-title":"J Pharm Sci"},{"key":"9546_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0378-5173(99)00091-5","volume":"184","author":"LH Chen","year":"1999","unstructured":"Chen LH, Chetty DJ, Chien YW. A mechanistic analysis to characterize oramucosal permeation properties. Int J Pharm. 1999;184:63\u201372.","journal-title":"Int J Pharm"},{"key":"9546_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.addr.2005.07.006","volume":"57","author":"V Grabovac","year":"2005","unstructured":"Grabovac V, Guggi D, Bernkop-Schn\u00fcrch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Del Rev. 2005;57:1713\u201323.","journal-title":"Adv Drug Del Rev"},{"key":"9546_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G","volume":"89","author":"JW Lee","year":"2000","unstructured":"Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850\u201366.","journal-title":"J Pharm Sci"},{"key":"9546_CR6","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","volume":"57","author":"JD Smart","year":"2005","unstructured":"Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Del Rev. 2005;57:1556\u201368.","journal-title":"Adv Drug Del Rev"},{"key":"9546_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-409X(94)90024-8","volume":"13","author":"MJ Rathbone","year":"1994","unstructured":"Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Del Rev. 1994;13:1\u201322.","journal-title":"Adv Drug Del Rev"},{"key":"9546_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0168-3659(99)00233-3","volume":"65","author":"Y Huang","year":"2000","unstructured":"Huang Y, Leobandung W, Foss A, Peppas NA. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Cont Rel. 2000;65:63\u201371.","journal-title":"J Cont Rel"},{"key":"9546_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/03639049309038765","volume":"19","author":"MR Jimen\u00e9z-Castellanos","year":"1993","unstructured":"Jimen\u00e9z-Castellanos MR, Zia H, Rhodes CT. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 1993;19:143\u201394.","journal-title":"Drug Dev Ind Pharm"},{"key":"9546_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0168-3659(01)00269-3","volume":"72","author":"S Senel","year":"2001","unstructured":"Senel S, Hincal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Rel. 2001;72:133\u201344.","journal-title":"J Control Rel"},{"key":"9546_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00137696-200402040-00006","volume":"2","author":"T Loftsson","year":"2004","unstructured":"Loftsson T, Brewster ME, M\u00e1sson M. Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv. 2004;2:1\u201315.","journal-title":"Am J Drug Deliv"},{"key":"9546_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2007.11.003","volume":"126","author":"L Matilainen","year":"2008","unstructured":"Matilainen L, Toropainen T, Vihola H, Hirvonen J, J\u00e4rvinen T, Jarho P, et al. In vitro toxicity and permeation of cyclodextrins in Calu-3 cells. J Control Rel. 2008;126:10\u20136.","journal-title":"J Control Rel"},{"key":"9546_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0378-5173(92)90053-5","volume":"84","author":"T Irie","year":"1992","unstructured":"Irie T, Wakamatsu K, Arima H, Aritomi H, Uekama K. Enhancing effects of cyclodextrins on nasal absorption of insulin in rats. Int J Pharm. 1992;84:129\u201339.","journal-title":"Int J Pharm"},{"key":"9546_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0168-3659(98)00182-5","volume":"59","author":"M Masson","year":"1999","unstructured":"Masson M, Loftsson T, M\u00e1sson G, Stef\u00e1nsson E. Cyclodextrins as permeation enhancers: some theorical evaluations and in vitro testing. J Control Rel. 1999;59:107\u201318.","journal-title":"J Control Rel"},{"key":"9546_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0169-409X(93)90038-6","volume":"12","author":"CA Squier","year":"1993","unstructured":"Squier CA, Wertz PW. Permeability and the pathophysiology of oral mucosa. Adv Drug Deliv Rev. 1993;12:13\u201324.","journal-title":"Adv Drug Deliv Rev"},{"key":"9546_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0731-7085(03)00204-8","volume":"32","author":"K Karljikovic-Rajic","year":"2003","unstructured":"Karljikovic-Rajic K, Novovic D, Marinkovic V, Agbaba D. First-order UV-derivative spectrophometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities. J Pharm Bio Anal. 2003;32:1019\u201327.","journal-title":"J Pharm Bio Anal"},{"key":"9546_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpba.2005.09.029","volume":"46","author":"T P\u00e9rez-Ruiz","year":"2006","unstructured":"P\u00e9rez-Ruiz T, Mart\u00ednez-Lozano C, Sanz A, Bravo E, Galera R. Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography. J Pharm Biom Anal. 2006;46:100\u20136.","journal-title":"J Pharm Biom Anal"},{"key":"9546_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jpba.2005.12.039","volume":"42","author":"N Markovic","year":"2006","unstructured":"Markovic N, Agotonovic-Kustrin S, Glass B, Prestidge CA. Physical and thermal characterisation of chiral omeprazole sodium salts. J Pharm Biom Anal. 2006;42:25\u201331.","journal-title":"J Pharm Biom Anal"},{"key":"9546_CR19","unstructured":"Min D.S., Um K.A., Kim Y.S., Park P.W., Method for preparing enteric-coated oral drugs containing acid-unstable compounds, USP Patent 1995."},{"key":"9546_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0731-7085(03)00233-4","volume":"33","author":"F Salama","year":"2003","unstructured":"Salama F, El-Abasawy N, Abdel-Razeq SA, Ismail MMF, Fouad MM. Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. J Pharm Biom Anal. 2003;33:411\u201321.","journal-title":"J Pharm Biom Anal"},{"key":"9546_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jchromb.2006.01.022","volume":"832","author":"M Shimizu","year":"2006","unstructured":"Shimizu M, Unoa T, Niioka T, Yaui-Furukori N, Takahata T, Sugawara K, et al. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: Application to pharmacokinetic study in relation to CYP2C19 genotypes. J Chromat B. 2006;832:241\u20138.","journal-title":"J Chromat B"},{"key":"9546_CR22","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jps.20450","volume":"95","author":"A Stroyer","year":"2005","unstructured":"Stroyer A, McGinity JW, Leopold CS. Solid State Interactions between the proton pump inhibitor omeprazole and various enteric coating polymers. J Pharm Sci. 2005;95:1342\u201353.","journal-title":"J Pharm Sci"},{"key":"9546_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0168-3659(00)00276-5","volume":"68","author":"H-G Choi","year":"2000","unstructured":"Choi H-G, Kim C-K. Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Rel. 2000;68:397\u2013404.","journal-title":"J Control Rel"},{"key":"9546_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0168-3659(00)00275-3","volume":"68","author":"H-G Choi","year":"2000","unstructured":"Choi H-G, Jung J-H, Yong CS, Rhee C-D, Lee M-K, Han J-H, et al. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J Control Rel. 2000;68:405\u201312.","journal-title":"J Control Rel"},{"key":"9546_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11095-006-9161-8","volume":"24","author":"A Figueiras","year":"2007","unstructured":"Figueiras A, Sarragu\u00e7a JMG, Carvalho RA, Pais AACC, Veiga FJB. Interaction of Omeprazole with a methylated derivative of \u03b2-Cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation. Pharm Res. 2007;24:377\u201389.","journal-title":"Pharm Res"},{"key":"9546_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1208\/s12249-009-9375-2","volume":"11","author":"A Figueiras","year":"2010","unstructured":"Figueiras A, Sarragu\u00e7a JMG, Pais AACC, Carvalho RA, Veiga FJ. The role of l-arginine in inclusion complexes of omeprazole with cyclodextrins. AAPS PharmSciTech. 2010;11:233\u201340.","journal-title":"AAPS PharmSciTech"},{"key":"9546_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejpb.2007.03.005","volume":"67","author":"A Figueiras","year":"2007","unstructured":"Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified \u03b2-cyclodextrin. Eur J Pharm Biopharm. 2007;67:531\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"9546_CR28","first-page":"126","volume":"60","author":"A Riedel","year":"2005","unstructured":"Riedel A, Leopold CS. Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study. Pharmazie. 2005;60:126\u201330.","journal-title":"Pharmazie"},{"key":"9546_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1081\/DDC-200047787","volume":"31","author":"A Riedel","year":"2005","unstructured":"Riedel A, Leopold CS. Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations. Drug Dev Ind Pharm. 2005;31:151\u201360.","journal-title":"Drug Dev Ind Pharm"},{"key":"9546_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejps.2004.05.001","volume":"23","author":"JC Richardson","year":"2004","unstructured":"Richardson JC, Dettmar PW, Hampson FC, Melia CD. Oseophageal bioadhesion of sodium alginate suspensions: particle swelling and mucosal retention. Eur J Pharm Sci. 2004;23:49\u201356.","journal-title":"Eur J Pharm Sci"},{"key":"9546_CR31","unstructured":"XXVIII U.S.P., Pharmacopeial Convention, Rockville, 2005"},{"key":"9546_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"1975","unstructured":"Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"9546_CR33","first-page":"64","volume":"20","author":"JW Moore","year":"1996","unstructured":"Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech. 1996;20:64\u201374.","journal-title":"Pharm Tech"},{"key":"9546_CR34","volume-title":"Immediate release solid oral dosage forms\u2014scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing, and in vivo bioequivalence documentation","author":"Food and Drug Administration (FDA), Center for Drug Evaluation and Research","year":"1995","unstructured":"Food and Drug Administration (FDA), Center for Drug Evaluation and Research. Immediate release solid oral dosage forms\u2014scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing, and in vivo bioequivalence documentation. Rockville: FDA, Food and Drug Administration, Center for Drug Evaluation and Research; 1995."},{"key":"9546_CR35","volume-title":"Dissolution testing of immediate release solid oral dosage forms","author":"Food and Drug Administration, Center for Drug Evaluation and Research","year":"1997a","unstructured":"Food and Drug Administration, Center for Drug Evaluation and Research. Dissolution testing of immediate release solid oral dosage forms. Rockville: FDA, Food and Drug Administration, Center for Drug Evaluation and Research; 1997a."},{"key":"9546_CR36","volume-title":"SUPAC-MR: modified release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing, and in vivo bioequivalence documentation","author":"Food and Drug Administration (FDA), Center for Drug Evaluation and Research","year":"1997b","unstructured":"Food and Drug Administration (FDA), Center for Drug Evaluation and Research. SUPAC-MR: modified release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing, and in vivo bioequivalence documentation. Rockville: FDA, Food and Drug Administration, Center for Drug Evaluation and Research; 1997b."},{"key":"9546_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jconrel.2004.12.001","volume":"103","author":"L Ribeiro","year":"2005","unstructured":"Ribeiro L, Ferreira DC, Veiga FJB. In vitro controlled release of vinpocetine\u2013cyclodextrin\u2013tartaric acid multicomponent complexes from HPMC swellable tablets. J Control Release. 2005;103:325\u201339.","journal-title":"J Control Release"},{"key":"9546_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0168-3659(03)00033-6","volume":"89","author":"FO Costa","year":"2003","unstructured":"Costa FO, Sousa JJ, Pais AACC, Formosinho SJ. Comparison of dissolution profiles of ibuprofen pellets. J Cont Rel. 2003;89:199\u2013212.","journal-title":"J Cont Rel"},{"key":"9546_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123\u201333.","journal-title":"Eur J Pharm Sci"},{"key":"9546_CR40","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s11095-005-7894-4","volume":"22","author":"N Langoth","year":"2005","unstructured":"Langoth N, Bernkop-Schn\u00fcrch A, Kurka P. In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclose-activating polypeptide). Pharm Res. 2005;22:2045\u201350.","journal-title":"Pharm Res"},{"key":"9546_CR41","first-page":"15","volume":"1","author":"AH Shojaei","year":"1998","unstructured":"Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharmaceut Sci. 1998;1:15\u201330.","journal-title":"J Pharm Pharmaceut Sci"},{"key":"9546_CR42","first-page":"11","volume-title":"The role of water movement and polymer hydration in mucoadhesion, in bioadhesive drug delivery systems\u2014fundamentals, novel approaches and development, D.E.C.I. E. Mathiowitz, and C.-M. Lehr","author":"JD Smart","year":"1999","unstructured":"Smart JD. The role of water movement and polymer hydration in mucoadhesion, in bioadhesive drug delivery systems\u2014fundamentals, novel approaches and development, D.E.C.I. E. Mathiowitz, and C.-M. Lehr. New York: Marcel Dekker; 1999. p. 11\u201324."},{"key":"9546_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1208\/s12249-008-9060-x","volume":"9","author":"H Li","year":"2008","unstructured":"Li H, Hardy RJ, Gu X. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech. 2008;9:437\u201343.","journal-title":"AAPS PharmSciTech"},{"key":"9546_CR44","first-page":"198","volume":"3","author":"P Colombo","year":"2000","unstructured":"Colombo P, Bettini R, Santi P. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. PSTT. 2000;3:198\u2013204.","journal-title":"PSTT"},{"key":"9546_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1023\/A:1011976615750","volume":"15","author":"VP Shah","year":"1998","unstructured":"Shah VP, Tsong Y, Sathe P, Liu JP. In vitro dissolution profile comparison\u2014statistics and analysis of the similarity factor, f2. Pharm Res. 1998;15:889\u201396.","journal-title":"Pharm Res"},{"key":"9546_CR46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.2042-7158.1972.tb08930.x","volume":"24","author":"F Langenbucher","year":"1972","unstructured":"Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979\u201381.","journal-title":"J Pharm Pharmacol"},{"key":"9546_CR47","volume-title":"Applied regression analysis: a research tool","author":"JO Rawlings","year":"1988","unstructured":"Rawlings JO. Applied regression analysis: a research tool. CA: Belmont; 1988."},{"key":"9546_CR48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.2042-7158.1978.tb13253.x","volume":"30","author":"JA Goldsmith","year":"1978","unstructured":"Goldsmith JA, Randall N, Ross SD. On methods of expressing dissolution rate data. J Pharm Pharm. 1978;30:347\u20139.","journal-title":"J Pharm Pharm"},{"key":"9546_CR49","first-page":"44","volume-title":"Statistical optimization of a controlled release formulation obtained by a double compression process: application of a hadamard matrix and a factorial design, in Pharmaceutical Technology, Controlled Drug Release, R. J.I. Wells, M.H","author":"P Romero","year":"1991","unstructured":"Romero P, Costa JB, Castel-Maroteaux X, Chulia D. Statistical optimization of a controlled release formulation obtained by a double compression process: application of a hadamard matrix and a factorial design, in Pharmaceutical Technology, Controlled Drug Release, R. J.I. Wells, M.H. New York: Ellis Harwood; 1991. p. 44\u201358."},{"key":"9546_CR50","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/jps.2600671034","volume":"67","author":"PV Pedersen","year":"1978","unstructured":"Pedersen PV, Myrick JW. Versatile kinetic approach to analysis of dissolution data. J Pharm Sci. 1978;67:1450\u20135.","journal-title":"J Pharm Sci"},{"key":"9546_CR51","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.2042-7158.1980.tb13002.x","volume":"32","author":"FN Christensen","year":"1980","unstructured":"Christensen FN, Hansen FY, Bechgaard H. Physical interpretation of parameters in the Rosin-Rammler-Sperling-Weibull distribution for drug release from controlled release dosage forms. J Pharm Pharmacol. 1980;32:580\u20132.","journal-title":"J Pharm Pharmacol"},{"key":"9546_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijpharm.2004.02.006","volume":"276","author":"JM Llabot","year":"2004","unstructured":"Llabot JM, Manzo RH, Allemandi DA. Drug release from carbomer\/carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int J Pharm. 2004;276:59\u201366.","journal-title":"Int J Pharm"},{"key":"9546_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0378-5173(94)00227-V","volume":"115","author":"NE Cooke","year":"1995","unstructured":"Cooke NE, Chen C. A contribution to a mathematical theory for polymer-based controlled release devices. Int J Pharm. 1995;115:17\u201327.","journal-title":"Int J Pharm"},{"key":"9546_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/imamat\/55.1.49","volume":"55","author":"DA Edwards","year":"1995","unstructured":"Edwards DA. The effect of a changing diffusion coefficient in super-Case II polymer-penetrant systems. SIMA J Appl Math. 1995;55:49\u201366.","journal-title":"SIMA J Appl Math"},{"key":"9546_CR55","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1137\/S003613999325405X","volume":"55","author":"DA Edwards","year":"1995","unstructured":"Edwards DA. An unusual moving boundary condition arising in anomalous diffusion problems. SIMA J Appl Math. 1995;55:662\u201375.","journal-title":"SIMA J Appl Math"},{"key":"9546_CR56","first-page":"269","volume":"1","author":"R Collins","year":"1998","unstructured":"Collins R. Mathematical modelling of controlled release from implanted drug-impregnated monoliths. PSTT. 1998;1:269\u201376.","journal-title":"PSTT"},{"key":"9546_CR57","unstructured":"Wise D.L., Drug Release from Swelling-Controlled Systems, in Handbook of Pharmaceutical Controlled Release Technology, D.L. Wise, Marcel Dekker: New York, Basel p. 183\u2013209."},{"key":"9546_CR58","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0003-9969(86)90006-3","volume":"31","author":"CA Squier","year":"1986","unstructured":"Squier CA, Cox PS, Wertz PW, Downing DW. The lipid composition of porcine epidermis and oral epithelium. Arch Oral Biol. 1986;31:741\u20137.","journal-title":"Arch Oral Biol"},{"key":"9546_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-409X(93)90037-5","volume":"12","author":"PW Wertz","year":"1993","unstructured":"Wertz PW, Swartzendruber DC, Squier CA. Regional variation in the structure and permeability of oral mucosa and skin. Adv Drug Deliv Rev. 1993;12:1\u201312.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-010-9546-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-010-9546-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-010-9546-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-010-9546-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:48:12Z","timestamp":1559620092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-010-9546-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,30]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9546"],"URL":"https:\/\/doi.org\/10.1208\/s12249-010-9546-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,30]]}}}